According to our new market research study on “Native Bacterial and Viral Antigens Market to 2027 – Global Analysis and Forecast – by Product Type, Pathogen Type, Application, and End User,” the market is expected to reach US$ 28,801.15 thousand by 2027 from US$ 17,105.05 thousand in 2019; it is estimated to grow at a CAGR of 6.8% from 2020 to 2027. The report highlights trends prevailing in the global native bacterial and viral antigens market, and the drivers and restraints pertaining to the market growth.

(**Note: The sample of this report is updated with COVID-19 impact analysis**)

To Know How COVID-19 Pandemic Will Impact Global Native Bacterial and Viral Antigens Market | Get a Sample Copy of Report, Click Here: https://www.theinsightpartners.com/sample/TIPRE00014757/ 

On the basis of product type, the native bacterial and viral antigens market is segmented into chlamydia antigens, adenovirus antigens, borrelia antigens, clostridium antigens, chikungunya virus antigens, and dengue virus antigens. The chlamydia antigens segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR during the forecast period. Growth of the market for this segment is attributed to easy availability of these antigens, with majority of the market players commercially offering these antigens in the native forms.

The global native bacterial and viral antigens market growth is mainly attributed to factors such as increasing use of native microbial antigens in diagnostics and therapeutics, and rising prevalence of infectious diseases. However, limitations associated with native antigens such as high cost, low antigen production levels, and scale-up difficulties may hinder the market growth.

BIO-RAD LABORATORIES INC., Microbix Biosystems, SERION Immunologics, Aalto Bio Reagents Ltd, Enzo Life Sciences Inc., Jena Bioscience GmbH, ROSS SOUTHERN LABORATORIES, The Native Antigen Company, Creative Diagnostics, and TRINA BIOREACTIVES AG are among the leading companies operating in the native bacterial and viral antigens market.

The Report Segments Global Native Bacterial and Viral Antigens Market as Follows:

By Product Type

  • Chlamydia Antigens 
  • Adenovirus Antigens
  • Borrelia Antigens
  • Chikungunya Virus Antigens
  • Clostridium Antigens
  • Dengue Virus Antigens

By Product Type

  • Inactivated Pathogen
  • Purified Pathogen

By Application

  • ELISA
  • Immunoassay
  • SDS-PAGE
  • Hemagglutination
  • Agglutination Test

By End User

  • Diagnostic Laboratories and Centers
  • Academic and Research Institutes

By Geography

  • North America
      • US
      • Canada
      • Mexico
  • Europe
      • France
      • Germany
      • UK
      • Spain
      • Italy
  • Asia Pacific (APAC)
      • China
      • India
      • Japan
      • Australia
      • South Korea
  • Middle East and Africa (MEA)
      • Saudi Arabia
      • UAE
      • South Africa
  • South and Central America (SCAM)
      • Brazil
      • Argentina